National Health Investors (NHI) Shares Sink as Hilliard Lyons Cuts to Underperform
Tweet
Share
E-mailGet Alerts NHI Hot Sheet
Price: $72.95 +2.36%
Rating Summary:
8 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 8
Rating Summary:
8 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 8
Join SI Premium – FREE
Shares of National Health Investors (NYSE: NHI) have tumbled in afternoon trade Thursday as Hilliard Lyons' John Roberts just issued an intraday downgrade on the stock. Roberts now rates National Health Investors shares an Underperform, down from Neutral previously.
The downgrade follows Q4 results and FY12 guidance Wednesday afternoon.
Shares of National Health Investors are now down 1.1 percent to $48.18.
For an analyst ratings summary and ratings history on National Health Investors click here. For more ratings news on National Health Investors click here.
The downgrade follows Q4 results and FY12 guidance Wednesday afternoon.
Shares of National Health Investors are now down 1.1 percent to $48.18.
For an analyst ratings summary and ratings history on National Health Investors click here. For more ratings news on National Health Investors click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Nomura/Instinet Downgrades Indraprastha Gas Ltd. (IGL:IN) to Neutral
- Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy
Create E-mail Alert Related Categories
DowngradesRelated Entities
Hilliard Lyons, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
